Font Size: a A A

Clinical Study Of Allo-HSCT With FLAG Conditioning Regimen In The Treatment Of Children High Risk Acute Leukemia

Posted on:2019-03-08Degree:MasterType:Thesis
Country:ChinaCandidate:Y ZhaoFull Text:PDF
GTID:2394330545951240Subject:Pediatrics
Abstract/Summary:PDF Full Text Request
Objective: The FLAG with the BUCY regimen are be used in preconditioning of children high-risk acute leukemia before allo-HSCT in our study.To Investigate the security and efficacy of FLAG conditioning regimen and to explore its application value in the treatment of children high-risk acute leukemia.Methods: We retrospectively analyzed 31 children with high risk acute leukemia who were treated with allo-HSCT in Department of Hematology,the Affiliated Children's Hospital of Suzhou University,From April 8th 2011 to August 19 th 2017.FLAG combined with BUCY regimen was given before allo-HSCT.The time of hematopoietic reconstitution,time and the degree of acute and chronic GVHD,Post-transplant infection(CMV?EBV),transplant related complications(VOD,HC),postoperative recurrence and survival were observed.Spss21.0 is used to describe the sample data.OS?DFS?the cumulative incidence of GVHD and recurrence rate were analyzed by kaplan-meier method and the survival curve was drawn.The survival rate was compared with log-rank test.Fisher exact probability method was used to compare the composition ratio between the two groups.The difference It will be considered statistically significant diffent if P<0.05.Results: 1.30 out of 31 patients achieved hematopoietic reconstitution after transplantation.The median reconstitution time of granulocyte hematopoiesis was 13(10-31)days.The median time of hematopoietic reconstitution in megakaryocytes was 19(7-167)days.2.At the end of the follow-up period,the 5years overall survival rate of all the children was 93.1%.The 5years disease-free survival rate is 90%.The cumulative recurrence rate is 10%.The median survival time was 13(1-79)months.Transplantationrelated mortality rate was 0.3.The cumulative incidence of aGVHD(acute graft-versus-host disease)was 64.5%,the median time of occurrence is 17(7-47)days,The cumulative incidence of cGVHD(chronic graft-versus-host disease)was 12.8%(3 cases),Occurred at 182 d,187d and 280 d after transplantation,The infection rate of CMV was 48.4%(15 cases).The infection rate of EBV was 22.6%(7cases).The incidence of hemorrhagic cystitis was 16.1%.No hepatic vein occlusion was found in all the children after transplantation.Conclusion: For high risk acute leukemia children with FLAG conditioning regimen,it has the advantage of high implantation rate,early hematopoietic reconstitution,and fewer transplant related complications.FLAG conditioning regimen has certain clinical application value.
Keywords/Search Tags:High risk refractory, acute leukemia, FLAG conditionin regimen, Allogeneic hematopoietic stem cell transplantation
PDF Full Text Request
Related items
Effects Of FLAG Regimen In Treatment Refractory And Relapsed Acute Myeloid Leukemia
The Compared Study Of Haploidentical Hematopoietic Stem Cell Transplantation For High-risk Refractory Acute Leukemia And The Improvement Post Transplantation
Efficacy Analysis Of Allogeneic Hematopoietic Stem Cell Transplantation With Cladribine Intensive Conditioning Regimen In The Treatment Of High-risk Acute Myeloid Leukemia
Intravenous Busulfan As A Preparative Regimen Before Allogeneic Hematopoietic Stem Cell Transplantation For Adult Patients With Acute Leukemia1
Clinical Research Of Cytomegalovirus(CMV) Infection In Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
A Clinical Study Of Decitabine Combined With Standard Conditioning Regimen Prior To Allo-HSCT In The Treatment Of Relapse/refractory Acute Myeloid Leukemia
Clinical And Laboratory Study Of Refractory Or Relapsed Acute Myeloid Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Research Of Once-daily Intravenous Busulfan-based Conditioning Regimen Prior To Allogeneic Hematopoietic Stem Cell Transplantation And Hematopoietic Stem Cell Transplantation In The Treatment Of Non-malignant Diseases
A 5-day Course Of Fludarabine And Cytarabine Followed By Full Intensity Allogeneic Stem Cell Transplantation(FA5-BUCY) In Treating Patients With High-risk, Refractory Or Recurrent Leukemia And Advanced Myelodysplastic Syndrome
10 Medium-dose VP-16 Intensified Conditioning Regimen Is Effective In Allogeneic Hematopoietic Stem Cell Transplantation For Acute Lymphoblastic Leukemia